Budapest, Hungary

Csilla Majláth

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Csilla Majláth. Retrieved from https://idiyas.com/inventor/csilla-majlandaacuteth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Csilla Majláth: Innovator in Pharmaceutical Chemistry

Introduction

Csilla Majláth is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative processes in drug preparation. Her work has led to the development of a unique compound that holds promise in medical applications.

Latest Patents

Csilla Majláth holds a patent for a process titled "PROCESS FOR THE PREPARATION OF N-(1,1-DIMETHYLETHYL)-4-[[5'-ETHOXY-4-CIS[2-(4-MORPHOLINO)ETHOXY]-2'-OXOSPIRO[CYCLOHEXAN-1,3'H]INDOL]1'(2'-H)-YL]-SULFONYL]-3-METHOXYBENZAMIDE AND ITS SALTS." This invention relates to a method for preparing a compound by reacting specific chemical formulas in dimethyl sulfoxide at controlled temperatures. The resulting compound can be transformed into its salt form using established methods.

Career Highlights

Csilla is currently associated with Sanofi-Synthelabo, a leading global healthcare company. Her role involves research and development in pharmaceutical formulations, where she applies her expertise to create innovative solutions for health challenges.

Collaborations

Throughout her career, Csilla has collaborated with talented professionals, including Gergely Héja and Éva Csikós. These partnerships have enhanced her research efforts and contributed to the advancement of her projects.

Conclusion

Csilla Majláth's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. Her patent and collaborative efforts highlight her commitment to advancing medical science through inventive processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…